Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer (ECOG-E2804)
Different combinations of bevacizumab, temsirolimus, and sorafenib compared with bevacizumab alone to treat patients with metastatic kidney cancer
Zoledronic Acid and Prostate Cancer (CALGB-90202)
Early vs. standard zoledronic acid and prostate cancer metastases
Flavopiridol and B-cell leukemia (CLLRC-OSU-049)
Flavopiridol for patients with previously treated B-cell leukemia
Sunitinib vs Sorafenib in Kidney Cancer (ECOG-E2805)
Adjuvant sunitinib vs sorafenib vs placebo in pts with resected renal cell carcinoma
Adding Bevacizumab or Cetuximab in Colorectal Cancer (CALGB-C80405)
Chemo plus bevacizumab or cetuximab or both for untreated metastatic colorectal cancer
Adding Bevacizumab in Advanced Ovarian Cancer (GOG-0218)
Chemotherapy and bevacizumab for women with advanced ovarian cancer
National Computed Tomography Colonography Trial (ACRIN 6664)